SyntheX
Developer of a proprietary drug discovery platform designed to find protein interaction disruptors, bridgers, and molecular glue degraders. The company utilizes genetically engineered circuits, techno...
Valuation
$0
Share Price
N/A
Total Raised
$11.6M
Last Round
N/A